Neuropeptides
Volume 41, Issue 1 , Pages 25-31, February 2007

Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors

  • T. Goto

      Affiliations

    • Division of Anatomy, Kyushu Dental College, 2-6-1 Manazuru, Kitakyushu 803-8580, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 93 582 1131; fax: +81 93 591 8199.
  • ,
  • K. Nakao

      Affiliations

    • Division of Orofacial Functions and Orthodontics, Kyushu Dental College, Kitakyushu 803-8580, Japan
  • ,
  • K.K. Gunjigake

      Affiliations

    • Division of Orofacial Functions and Orthodontics, Kyushu Dental College, Kitakyushu 803-8580, Japan
  • ,
  • M.A. Kido

      Affiliations

    • Laboratory of Oral Anatomy and Cell Biology, Graduate School of Dental Science, Kyushu University, Fukuoka 812-8582, Japan
  • ,
  • S. Kobayashi

      Affiliations

    • Division of Anatomy, Kyushu Dental College, 2-6-1 Manazuru, Kitakyushu 803-8580, Japan
  • ,
  • T. Tanaka

      Affiliations

    • Laboratory of Oral Anatomy and Cell Biology, Graduate School of Dental Science, Kyushu University, Fukuoka 812-8582, Japan

Received 4 May 2006; accepted 8 November 2006. published online 04 January 2007.

Abstract 

Substance P (SP) is a widely distributed neuropeptide that works as a neurotransmitter and neuromodulator. Recently, SP receptors, particularly neurokinin-1 receptors (NK1-Rs) that have a high affinity for SP, have been observed not only in neuron and immune cells, but also in other peripheral cells, including bone cells. To identify the role of SP in bone formation, we investigated the expression of NK1-Rs in osteoblastic cells and the effects of SP on bone formation by rat calvarial osteoblastic cells. Rat calvarial osteoblastic cells were isolated and cultured for 3 weeks in alpha-MEM containing 10% serum, ascorbic acid, dexamethasone, and beta-glycerophosphate. We then investigated NK1-R expression, SP effects on osteoblastic bone formation, and osteocalcin mRNA expression in osteoblastic cells. RT-PCR and immunocytochemistry showed that NK1-R mRNA was expressed and NK1-R was present in 14-day, but not 7-day, cultured calvarial osteoblasts. Bone formation by cultured osteoblastic cells significantly increased after the addition of 10−8–10−6MSP. During 3 weeks of culture, the addition of SP in the first week did not significantly increase bone formation, whereas adding SP during the first and second week or all 3 weeks significantly increased calvarial osteoblastic bone formation. Furthermore, semi-quantitative RT-PCR indicated that SP stimulated osteocalcin mRNA expression in the osteoblasts at day 14 or day 21, whereas SP did not stimulated the runX2 or type I collagen mRNA expression at day 7 but stimulated them at day 14. These results indicate that SP stimulates bone formation by osteoblastic cells via NK1-Rs at late-stage bone formation. These effects were dependent on the expression of NK1-R in osteoblastic cells. Our findings suggest that SP secreted from sensory neurons may modulate bone formation after the expression of SP receptors.

Keywords: Bone formation, Neurokinin-1 receptor, Osteoblastic cell, Substance P

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0143-4179(06)00149-1

doi:10.1016/j.npep.2006.11.002

Neuropeptides
Volume 41, Issue 1 , Pages 25-31, February 2007